Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 2/20 | 0.34 |
| ▸ | PDE4D | Q08499 | 14/20 | 0.34 |
| ▸ | PDE4A | P27815 | 9/20 | 0.34 |
| ▸ | PDE4B | Q07343 | 9/20 | 0.34 |
| ▸ | PDE4C | Q08493 | 9/20 | 0.34 |
| ▸ | CTSL | P07711 | 1/20 | 0.33 |
| ▸ | ATF4 | P18848 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17517935 | 0.82 | CTSL (0.36) | NAAAPDE4DPDE4APDE4BPDE4C | |
| SCHEMBL29830733 | 0.82 | PDE4D (0.45) | NAAAPDE4DPDE4APDE4BPDE4C | |
| SCHEMBL30720976 | 0.81 | NAAA (0.37) | NAAAPDE4DPDE4APDE4BPDE4C | |
| SCHEMBL8230175 | 0.78 | PDE4D (0.38) | NAAAPDE4DPDE4APDE4BPDE4C | |
| SCHEMBL13351589 | 0.78 | PDE4D (0.38) | NAAAPDE4DPDE4APDE4BPDE4C | |
| SCHEMBL13351557 | 0.78 | PDE4D (0.38) | NAAAPDE4DPDE4APDE4BPDE4C | |
| SCHEMBL23049716 | 0.78 | CTSL (0.34) | PDE4DPDE4APDE4BPDE4CCTSL | |
| SCHEMBL24186291 | 0.78 | CTSL (0.34) | PDE4DPDE4APDE4BPDE4CCTSL | |
| SCHEMBL12475327 | 0.78 | CTSL (0.34) | PDE4DPDE4APDE4BPDE4CCTSL | |
| SCHEMBL23049719 | 0.78 | CTSL (0.34) | PDE4DPDE4APDE4BPDE4CCTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023178133-A9 | COMPOUNDS AND METHODS FOR TREATING DISEASE | ROME THERAPEUTICS, INC. (US) | 2023-10-26 | — | — | WO | disclosed |
| WO-2023178133-A1 | COMPOUNDS AND METHODS FOR TREATING DISEASE | ROME THERAPEUTICS, INC. (US) | 2023-09-21 | — | — | WO | disclosed |